Search Results - "Huhtakangas, J."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Systemic sclerosis: changes in the incidence rates in the Finnish population during the years 1999-2018 by Kortelainen, S, Käyrä, M, Hurme, S, Paltta, J, Pirilä, L, Huhtakangas, J

    “…The aim of our study was to examine changes in the incidence of systemic sclerosis (SSc) in Finland using two different classification criteria. Medical…”
    Get full text
    Journal Article
  2. 2

    Causes and predictors of death among Finnish patients with systemic sclerosis by Kortelainen, S, Käyrä, M, Rissanen, T, Paltta, J, Taimen, K, Pirilä, L, Huhtakangas, J

    Published in Scandinavian journal of rheumatology (03-07-2024)
    “…The aim of this study was to assess causes and predictors of death among Finnish patients with systemic sclerosis (SSc). Medical records of patients registered…”
    Get full text
    Journal Article
  3. 3

    The validity of systemic sclerosis diagnoses in two university hospitals in Finland by Paltta, J, Kortelainen, S, Käyrä, M, Pirilä, L, Huhtakangas, J, Palomäki, A

    “…This study aimed to determine the validity of systemic sclerosis (SSc) diagnoses in Finnish university hospitals. Electronic medical records for 385 patients…”
    Get full text
    Journal Article
  4. 4

    The validity of rheumatoid arthritis diagnoses in Finnish biobanks by Paltta, J, Heikkilä, H-K, Pirilä, L, Eklund, KK, Huhtakangas, J, Isomäki, P, Kaipiainen-Seppänen, O, Kristiansson, K, Havulinna, AS, Sokka-Isler, T, Palomäki, A

    Published in Scandinavian journal of rheumatology (02-01-2023)
    “…The aim of this study was to determine the validity of rheumatoid arthritis (RA) diagnoses in patients participating in Finnish biobanks. We reviewed the…”
    Get full text
    Journal Article
  5. 5

    Early vs. late enoxaparin for the prevention of venous thromboembolism in patients with ICH: A double blind placebo controlled multicenter study by Qian, C., Huhtakangas, J., Juvela, S., Bode, M.K., Tatlisumak, T., Savolainen, M., Numminen, H., Ollikainen, J., Luostarinen, L., Kupila, L., Tetri, S.

    Published in Clinical neurology and neurosurgery (01-03-2021)
    “…•Venous thromboembolism in paralyzed ICH patients is nowadays very rare, if prophylaxix guidelines are followed strictly.•This double blind study shows that it…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Better than expected survival after primary intracerebral hemorrhage in patients with untreated hypertension despite high admission blood pressures by Tetri, S., Huhtakangas, J., Juvela, S., Saloheimo, P., Pyhtinen, J., Hillbom, M.

    Published in European journal of neurology (01-05-2010)
    “…Background:  Hypertension is the most important modifiable risk factor for primary intracerebral hemorrhage (ICH), but little is known of the effect of…”
    Get full text
    Journal Article
  9. 9

    Negative regulation of human parathyroid hormone gene promoter by vitamin D3 through nuclear factor Y by Jääskeläinen, T, Huhtakangas, J, Mäenpää, P H

    “…The negative regulation of the human parathyroid hormone (PTH) gene by biologically active vitamin D3 (1,25-dihydroxyvitamin D3; 1,25(OH)2D3) was studied in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Presence of a Truncated Form of the Vitamin D Receptor (VDR) in a Strain of VDR-Knockout Mice by Bula, Craig M, Huhtakangas, Johanna, Olivera, Christopher, Bishop, June E, Norman, Anthony W, Henry, Helen L

    Published in Endocrinology (Philadelphia) (01-12-2005)
    “…As part of our studies on the membrane-initiated actions of 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3] and its localization in caveolae membrane fractions, we…”
    Get full text
    Journal Article
  12. 12

    Negative regulation of human parathyroid hormone gene promoter by vitamin D 3 through nuclear factor Y by Jääskeläinen, T., Huhtakangas, J., Mäenpää, P.H.

    “…The negative regulation of the human parathyroid hormone (PTH) gene by biologically active vitamin D 3 (1,25-dihydroxyvitamin D 3; 1,25(OH) 2D 3) was studied…”
    Get full text
    Journal Article
  13. 13

    Negative regulation of human parathyroid hormone gene promoter by vitamin D sub(3) through nuclear factor Y by Jaaskelainen, T, Huhtakangas, J, Maenpaa, PH

    “…The negative regulation of the human parathyroid hormone (PTH) gene by biologically active vitamin D sub(3) (1,25-dihydroxyvitamin D sub(3); 1,25(OH) sub(2)D…”
    Get full text
    Journal Article
  14. 14

    Evidence that annexin II Is not a putative membrane receptor for 1α,25(OH) 2 ‐vitamin D 3 by Mizwicki, Mathew T., Bishop, June E., Olivera, Christopher J., Huhtakangas, Johanna, Norman, Anthony W.

    Published in Journal of cellular biochemistry (01-03-2004)
    “…Abstract The seco‐steroid hormone 1α,25(OH) 2 ‐vitamin D 3 (1,25‐D 3 ) is known to generate biological responses via both genomic and non‐genomic rapid signal…”
    Get full text
    Journal Article
  15. 15

    The validity of systemic sclerosis diagnoses in two university hospitals in Finland by Paltta, J, Kortelainen, S, Käyrä, M, Pirilä, L, Huhtakangas, J, Palomäki, A

    Published in Scandinavian Journal of Rheumatology (02-01-2023)
    “…This study aimed to determine the validity of systemic sclerosis (SSc) diagnoses in Finnish university hospitals. Electronic medical records for 385 patients…”
    Get full text
    Report